HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Another ten stories in antiviral drug discovery (part C): "Old" and "new" antivirals, strategies, and perspectives.

Abstract
The ten stories told here deal with (i) ribavirin as an inhibitor of IMP dehydrogenase and (ii) ribavirin, in combination with pegylated interferon, as the present "standard of care" for hepatitis C; (iii) S-adenosylhomocysteine hydrolase inhibitors as antiviral agents; (iv) new adamantadine derivatives for the treatment of influenza A virus infections; (v) 5-substituted 2'-deoxyuridines (i.e. IDU, TFT) for the treatment of herpes simplex virus (HSV) infections; (vi) acyclic guanosine analogues (e.g. acyclovir) for the treatment of HSV infections; (vii) OMP decarboxylase inhibitors (i.e. pyrazofurin) and CTP synthetase inhibitors (i.e. cyclopentenylcytosine) as possible antiviral agents; (viii) the future of cidofovir (and alkoxyalkyl esters thereof) and ST-246 as potential antipoxvirus agents; (ix) the two decade journey from tivirapine to rilpivirine in the ultimate therapy of HIV infections; and (x) the extension of the therapeutic application of tenofovir disoproxil fumarate (Viread) to the treatment of hepatitis B virus infection, in addition to HIV infection.
AuthorsErik De Clercq
JournalMedicinal research reviews (Med Res Rev) Vol. 29 Issue 4 Pg. 611-45 (Jul 2009) ISSN: 1098-1128 [Electronic] United States
PMID19260077 (Publication Type: Journal Article, Review)
Chemical References
  • Antiviral Agents
  • HIV Protease Inhibitors
  • Ribavirin
  • IMP Dehydrogenase
Topics
  • Antiviral Agents (therapeutic use)
  • Drug Discovery (trends)
  • HIV Protease Inhibitors (therapeutic use)
  • Hepatitis C, Chronic (drug therapy, virology)
  • IMP Dehydrogenase (antagonists & inhibitors)
  • Ribavirin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: